The metabolic syndrome in type 2 diabetic patients in Gorgan: According to NCEP ATPIII and IDF definitions

被引:5
|
作者
Marjani, Abdoljalal [1 ]
Shirafkan, Ahmad [2 ]
机构
[1] Golestan Univ Med Sci, Gorgan Fac Med, Dept Biochem & Biophys, Gorgan, Golestan Provin, Iran
[2] Golestan Univ Med Sci, Gorgan Fac Med, Dept Cardiol, Gorgan, Golestan Provin, Iran
关键词
Gorgan; Metabolic syndrome; Type 2 diabetes mellitus; ATPIII and IDF;
D O I
10.1016/j.dsx.2012.02.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: People with metabolic syndrome are at increased risk for developing diabetes mellitus and cardiovascular disease. The present study aimed to assess the metabolic syndrome in type 2 diabetes and compare them with two used methods of diagnostic criteria in Gorgan. Methods: The study group included 293 type 2 diabetic patients whom referred to the Department of Diabetes Center in Golestan University of Medical Sciences (2011). The metabolic syndrome was determined according to ATPIII and IDF definitions. Results: According to ATPIII and IDF criteria, the frequency of metabolic syndrome was 75.42% and 76.79%, respectively. According to ATPIII, the mean triglycerides, body mass index, systolic blood pressure and diastolic blood pressure were higher in subjects with metabolic syndrome than subjects without metabolic syndrome. According to IDF, the mean triglycerides, body mass index and males' waist circumferences were higher in subjects with metabolic syndrome. Conclusions: This study showed that females were more affected than males. This may be due to the specific characteristics in the lifestyle changes between females and males diabetic patients among Gorgan inhabitants. Females are less educated in comparison with males diabetic. The majority of females with metabolic syndrome were householder. It seems that they do less physical activity at home. In conclusion, it appears that the female need to change their life style in this area to halt the burden of cardiovascular complications in diabetic patients. (C) 2012 Published by Elsevier Ltd on behalf of Diabetes India.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [31] Prevalence of metabolic syndrome and prediction of diabetes using IDF versus ATPIII criteria in a Middle East population
    Hajat, Cother
    Shather, Zainab
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 98 (03) : 481 - 486
  • [32] The Prevalence of Metabolic Syndrome According to Different Criteria and its Associated Factors in Type 2 Diabetic Patients in Kerman, Iran
    Foroozanfar, Zohre
    Najafipour, Hamid
    Khanjani, Narges
    Bahrampour, Abbas
    Ebrahimi, Hosseinali
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2015, 40 (06) : 522 - 525
  • [33] Comparing the association of two metabolic syndrome definitions, NCEP ATP III and IDF, with the risk of developing atherosclerotic cardiovascular disease: An analytical cross-sectional study
    Yousefzadeh, Gholamreza
    Sayyadi, Amin
    Najafipour, Hamid
    Sabaghnejad, Vida
    Pezeshki, Sara
    ENDOCRINOLOGY DIABETES & METABOLISM, 2024, 7 (01)
  • [34] Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: The Diabetes in Germany (DIG) study
    Koehler, C.
    Ott, P.
    Benke, I.
    Hanefeld, M.
    HORMONE AND METABOLIC RESEARCH, 2007, 39 (09) : 632 - 635
  • [35] Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone
    Derosa, G.
    Fogari, E.
    D'Angelo, A.
    Cicero, A. F. G.
    Salvadeo, S. A. T.
    Ragonesi, P. D.
    Ferrari, I.
    Gravina, A.
    Fassi, R.
    Fogari, R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (03) : 261 - 268
  • [36] Prevalence of Metabolic Syndrome According to Different Definitions in a Hypertensive Population
    Lioudaki, Eirini
    Vrentzos, George E.
    Mavrogeni, Helen
    Zeniodi, Maria-Helen
    Ganotakis, Emmanuel S.
    Mikhailidis, Dimitri P.
    Papadakis, John A.
    ANGIOLOGY, 2012, 63 (01) : 39 - 47
  • [37] Effects of glibenclamide and metformin on prevalence of metabolic syndrome in type 2 diabetic patients
    Mahmood, Isam Hamo
    Nazar, Weijdan
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (05) : 1033 - 1037
  • [38] Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients
    Yun, Ji Eun
    Sull, Jae Woong
    Lee, Hee Yeon
    Park, Eunjung
    Kim, Soriwool
    Jo, Jaeseong
    Lee, Sun Ju
    Kim, Sang Yeon
    Choi, Young Ju
    Jee, Sun Ha
    Huh, Kap Bum
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (03) : 259 - 265
  • [39] Prevalence of metabolic syndrome as per the NCEP and IDF definitions vis-a-vis severity and duration of psoriasis in a semi-urban Maharashtrian population: A case control study
    Sharma, Yugal K.
    Prakash, Naren
    Gupta, Aayush
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2016, 10 (02) : S72 - S76
  • [40] Analysis of Metabolic Syndrome's components by IDF in the female with diabetes mellitus type 2
    Rajewski, Pawel
    Rajewski, Piotr
    Waleskiewicz, Karolina
    Dobosz, Krzysztof
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2008, 10 (03) : 624 - 626